Outcomes Rocket Redefining Clinical Trials: Sasha Tyndale on Inclusive Research at AbbVie
9 snips
May 2, 2025 Sasha Tyndale, Director of Diversity and Patient Inclusion at AbbVie, brings 14+ years of expertise in clinical research to the forefront. She discusses the urgent need for inclusive clinical trials that reflect diverse populations affected by diseases. The ADMIRE program is highlighted as a key initiative to engage underrepresented healthcare providers. Sasha emphasizes the power of patient stories in shaping research and describes AbbVie's bold strategies to simplify trial participation and remove barriers, inviting listeners to become advocates for inclusive healthcare.
AI Snips
Chapters
Transcript
Episode notes
Early Spark From A Childhood Visit
- Sasha's mother brought her to 'Take Your Daughter to Work Day' at Johnson & Johnson which sparked her interest in clinical research.
- That early exposure led Sasha to a patient-centered career across pharma companies and CROs.
Design Trials To Match The Patient Population
- AbbVie designs trials to represent the people affected by the diseases they study to ensure confidence in safety and efficacy.
- Integrating patient perspectives into protocol design reduces barriers and improves relevance of trial results.
Bring Patients Into Protocol Design
- Involve patients and care partners early in protocol development to identify and mitigate participation barriers.
- Use their input proactively so studies require fewer reactive fixes during execution.